{"id":179970,"date":"2010-01-14T10:28:01","date_gmt":"2010-01-14T15:28:01","guid":{"rendered":"http:\/\/www.diabetesforums.com\/forum\/diabetes\/47616-long-acting-form-byetta.html"},"modified":"2010-01-14T10:28:01","modified_gmt":"2010-01-14T15:28:01","slug":"long-acting-form-of-byetta","status":"publish","type":"post","link":"https:\/\/mereja.media\/index\/179970","title":{"rendered":"Long-acting form of Byetta?"},"content":{"rendered":"<div>Guys<\/p>\n<p>I&#8217;m going to see my Endo on Wednesday, and was considering asking him again to put me on a GLP1 mimetic.<\/p>\n<p>( <a href=\"http:\/\/www.bioportfolio.com\/news\/DailyUpdates_70.htm\" >Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics<\/a> )<\/p>\n<p>The most common one is Byetta [Exenatide] (also jokingly known as Lizard Spit because it was originally extracted from the saliva of the Gila Monster lizard &#8230;). this needs to be injected at least twice a day.<\/p>\n<p>( <a href=\"http:\/\/en.wikipedia.org\/wiki\/Exenatide\" >Exenatide &#8211; Wikipedia, the free encyclopedia<\/a> )<\/p>\n<p>In Europe, a long acting formulation of this has been licensed &#8211; Victosa [Liraglutide], which only needs to be injected once per day. (It&#8217;s still undergoing final FDA Sign-off).<\/p>\n<p>( <a href=\"http:\/\/en.wikipedia.org\/wiki\/Liraglutide\" >Liraglutide &#8211; Wikipedia, the free encyclopedia<\/a> )<\/p>\n<p>Does anyone have any recommendations or experience regarding Victosa? Anyone any comments about Byetta?<\/p>\n<p>I already take 1500mg Glucophage and c.1600-2000 iu Humulin per day &#8230;<\/p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Guys I&#8217;m going to see my Endo on Wednesday, and was considering asking him again to put me on a GLP1 mimetic. ( Incomplete control of HbA1c levels is the major drawback to current non-insulin antidiabetics ) The most common one is Byetta [Exenatide] (also jokingly known as Lizard Spit because it was originally extracted [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[7],"tags":[],"class_list":["post-179970","post","type-post","status-publish","format-standard","hentry","category-news"],"_links":{"self":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/179970","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/comments?post=179970"}],"version-history":[{"count":0,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/posts\/179970\/revisions"}],"wp:attachment":[{"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/media?parent=179970"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/categories?post=179970"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mereja.media\/index\/wp-json\/wp\/v2\/tags?post=179970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}